- Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.
- Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.
- The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
- Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability.
- Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.
- Expression of tumour-specific antigens underlies cancer immunoediting.
- Suppression of lung adenocarcinoma progression by Nkx2-1.
- Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.
- Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer.